1. Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders
- Author
-
M Savarese, Marta Caretto, Tommaso Simoncini, R. Lecca, Carolina Lombardi, Federica Provini, Danila Caruso, Enrica Bonanni, M. C. Spaggiari, Rosalia Silvestri, Michelangelo Maestri, Maria R. Bonsignore, M. Miccoli, Monica Puligheddu, Irene Aricò, M.C. Di Perri, S. Galletta, Laura Palagini, Silvestri R., Arico I., Bonanni E., Bonsignore M., Caretto M., Caruso D., Di Perri M.C., Galletta S., Lecca R.M., Lombardi C., Maestri M., Miccoli M., Palagini L., Provini F., Puligheddu M., Savarese M., Spaggiari M.C., Simoncini T., Silvestri, R, Arico, I, Bonanni, E, Bonsignore, M, Caretto, M, Caruso, D, Di Perri, M, Galletta, S, Lecca, R, Lombardi, C, Maestri, M, Miccoli, M, Palagini, L, Provini, F, Puligheddu, M, Savarese, M, Spaggiari, M, Simoncini, T, Silvestri, R., Aricò, I., Bonanni, E., Bonsignore, M., Caretto, M., Caruso, D., Di Perri, M.C., Galletta, S., Lecca, R.M., Lombardi, C., Maestri, M., Miccoli, M., Palagini, L., Provini, F., Puligheddu, M., Savarese, M., Spaggiari, M.C., and Simoncini, T.
- Subjects
Sleep Initiation and Maintenance Disorder ,medicine.medical_treatment ,Serotonin and Noradrenaline Reuptake Inhibitor ,Position statement ,Sleep medicine ,0302 clinical medicine ,Sleep Initiation and Maintenance Disorders ,Cognitive behavioraltherapy for insomnia (CBT-I) ,Insomnia ,Sleep Wake Disorder ,030212 general & internal medicine ,Continuous positive airway pressure ,Restless legs syndrome ,Serotonin and Noradrenaline Reuptake Inhibitors ,Hormonereplacementtherapy (HRT) ,Menopause ,Sleepdisorders ,Vasomotorsymptoms (VMS) ,Sleep Apnea, Obstructive ,030219 obstetrics & reproductive medicine ,Continuous Positive Airway Pressure ,Depression ,Obstetrics and Gynecology ,Serotonin Uptake Inhibitor ,Antidepressive Agents ,Cognitive behavioral therapy ,Cognitive behavioral therapy for insomnia (CBT-I) ,Antidepressive Agent ,Female ,medicine.symptom ,Selective Serotonin Reuptake Inhibitors ,medicine.drug ,Human ,Sleep Wake Disorders ,medicine.medical_specialty ,Hormone Replacement Therapy ,Vasomotor symptoms (VMS) ,Mirtazapine ,Hormone replacement therapy (HRT) ,Sleep disorders ,Cognitive Behavioral Therapy ,Exercise ,Humans ,Quality of Life ,Restless Legs Syndrome ,Serotonin Uptake Inhibitors ,Sleep ,Settore MED/10 - Malattie Dell'Apparato Respiratorio ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,mental disorders ,medicine ,Sleep disorder ,business.industry ,medicine.disease ,nervous system diseases ,Obstructive sleep apnea ,Menopause, sleep disorders, vasomotor symptoms (VMS), hormone replacement therapy (HRT), Cognitive Behavioral Therapy for Insomnia (CBT-I), Position Statement ,Physical therapy ,business - Abstract
Insomnia, vasomotor symptoms (VMS) and depression often co-occur after the menopause, with consequent health problems and reductions in quality of life. The aim of this position statement is to provide evidence-based advice on the management of postmenopausal sleep disorders derived from a systematic review of the literature. The latter yielded results on VMS, insomnia, circadian rhythm disorders, obstructive sleep apnea (OSA) and restless leg syndrome (RLS). Overall, the studies show that menopausal hormone therapy (MHT) improves VMS, insomnia, and mood. Several antidepressants can improve insomnia, either on their own or in association with MHT; these include selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and mirtazapine. Long-term benefits for postmenopausal insomnia may also be achieved with non-drug strategies such as cognitive behavioral therapy (CBT) and aerobic exercise. Continuous positive airway pressure (CPAP) and mandibular advancement devices (MADs) both reduce blood pressure and cortisol levels in postmenopausal women suffering from OSA. However, the data regarding MHT on postmenopausal restless legs syndrome are conflicting.
- Published
- 2019